... American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. CA Cancer J Clin 2007;57;7-28. 10. American Cancer Society. BreastCancer ... America Sub-Saharan South Asia the Pacific Central Asia and North Africa and the Caribbean AfricaRegions Breastcancer Cervical cancer Ovarian cancer Corpus uteri cancer Colorectal cancer % of DALYs*percentage ... from breastcancer as compared to 218 000 deaths from cervical cancer. In high-income countries, 155 000 deaths are reported from breast cancer and much fewer –17 000– from cervical cancer. ...
... detect breast cancer. Clin Chem 2002;48(8): 1296–1304 27. Mathelin C. Cromer A, Wendling C, Tomasetto C, Rio MC: Serum biomarkers for detection of breast cancers: a prospective study. BreastCancer ... patients with pT1–2 breast cancer. Anticancer Res 2004; 24(5): 3221–3224. 11. Stein RC, Zvelebil MJ: The application of 2D gel-based prote-omics methods to the study of breast cancer. J Mammary ... early diagnosis of the BC. Key words: BreastCancer diagnosis, Serum Biomarkers, Bc1, Bc2, and Bc3 INTRODUCTION Breast cancer (BC) is the most common cancer among women in Westernized populations....
... recur-rent breastcancer with screening for second primary tumors in selected breast cancer survivors.EPIDEMIOLOGYExcluding cancers of the skin, breastcancer is the most common cancer among ... women who received estrogen alone, breastcancer incidence was higher in women who received estrogen plus progesterone than in those who received estrogen alone, such that the total cancer incidence ... gateway into M. D. Anderson and serves as one of M. D. Anderson’s links between healthy individuals and those affected by cancer. The Cancer Prevention Center’s breastcancer prevention program...
... D: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69–90. 2. American Cancer Association: Survival rates for breast cancer. Atlanta: 2012. http://www .cancer. org /Cancer/ BreastCancer/OverviewGuide /breast- cancer- overview-survival-rates. ... and breastcancerdoes not mean the end of life” (2, 2) Comfort in acquiring breast health knowledge and skills In all the FGDs, women talked about seeing or hearing about breastcancer and breast ... Franceschi D, Nystrom L: Breast cancer in limited-resource countries: early detection and access to care. Breast J 2006, 12(Suppl 1):S16–26. 18. Anderson BO, Tsu VD: Breastcancer in low and middle...
... suppressor genes BRCA1 and BRCA2 increase individual risks for breastcancer 60-85% and may be identified in 5-10% of all breastcancer cases.28 Personal history of noninvasive breastcancer ... screening decrease breastcancer mortality? Alone or with mammography?1c. Doesbreast self examination practice decrease breastcancer mortality?2a. What are the harms associated with screening ... Breast cancer is the most frequently diagnosed non-cutaneous cancer and the second leading cause of cancer deaths after lung cancer among women in the United States.7 In 2008, an Breast Cancer...
... the nature of the cancer. A similarpattern can be seen with prostate cancer in men, which shares somefeatures with breast cancer. 112NHS Breast Screening Programme/British Association of Surgical ... service they receive. 302Although 11,340 women died from breastcancer in England andWales in 2000 (Table 1), breastcancer survival rates are higher thanthose for any other major cancer in ... metastatic breastcancer (expected date of issue, April 2003)• Vinorelbine for breastcancer (expected date of issue, September 2002)Guideline and service guidance in progress• Familial breast cancer: ...
... MDChapter 9 Breast Cancer Cancer in 15- to 29-Year-Olds in the United StatesCHAPTER 9 BREAST CANCER SEER AYA Monograph 112 National Cancer InstituteHIGHLIGHTSIncidence • Breastcancer in adolescents ... receptor status in breastcancer patients. BreastCancer Res 2004;6:R488-98. 30. Ursin G, Ma H, Wu AH, et al.: Mammographic density and breastcancer in three ethnic groups. Cancer Epide-miol ... Cumulative absolute breastcancer risk for young women treated for Hodgkin Lymphoma. J Natl Cancer Inst 2005;97:1428-37.CHAPTER 9 BREAST CANCER SEER AYA Monograph 116 National Cancer InstituteData...
... experience in breastcancer research, this application must focus on breastcancer research. Applications must emphasize the PI’s high potential for success in becoming an independent breastcancer ... DoD FY12 BreastCancer Postdoctoral Fellowship 2 Award 3 I. FUNDING OPPORTUNITY DESCRIPTION A. Program Description Applications for the BreastCancer Research Program (BCRP) are being solicited ... individualized, breast cancer- focused training program, and describe how this training will facilitate the PI’s career development as an independent, innovative breastcancer researcher. A DoD FY12 Breast...
... the management of breast cancer. Br J Cancer 1988;57:604–7.(12) Rutqvist LE, Cedermark B, Glas U, Mattsson A, Skoog L, Somell A, et al.Contralateral primary tumors in breastcancer patients in ... Heuson JC. Current overview of EORTC clinical trials with tamoxifen. Cancer Treat Rep 1976;60:1463–6.(2) Mouridsen H, Palshof T, Patterson J, Battersby L. Tamoxifen in advanced breast cancer. Cancer ... breast cancer refractory to combination chemotherapy. JAMA 1979;242:49–52.(4) Margreiter R, Wiegele J. Tamoxifen (Nolvadex) for premenopausal pa-tients with advanced breast cancer. Breast Cancer...
... for breastcancer in Norway: comparative analysis of cancer registry data. BMJ 2011;343:d4692. 20. NHS cancer screening programmes. BASO Breast Audit 1999/2000. www.cancerscreening.nhs.uk/breastscreen/publications.html ... of breast cancer. The absolute reduction in breastcancer mortality was therefore only 0.05%. Screening does not reduce the overall risk of dying, or the overall risk of dying from cancer ... dying from breast cancer because the screening detected the cancer earlier. Since these trials were undertaken, treatment of breastcancer has improved considerably. Women today also seek medical...
... University of Hamburg, Germany;2Imperial Cancer Research Fund BreastCancer Biology Group,Guy’s Hospital, London, UKMucin glycoproteins on breastcancer cells car ry shortenedcarbohydrate ... the amino acid tandemrepeat of a cancer- associated mucin, contains immunodominantepitopes. Int. J. Cancer 44, 691–696.14. Blockzjil, A., Nilsson, K. & Nilsson, O. (1998) Epitopecharacterization ... oligosaccharide s ide chains.These antigenic peptide sequences therefore constitute cancer- associated epitopes which are also found in theCorrespondence to B. Meyer, Institute of Organic Chemistry,University...
... how151Lung cancer is the leading cause of cancer deaths among U.S. women, with more than65,000 deaths annually (American Cancer Society, 2000; http://www3 .cancer. org/cancerinfo/).1Introduction Breast ... (unknown how much to early detection of breastcancer (e.g., digital breast cancer research) mammography). Photonics PartnershipInitiative will investigate possibilities forearly breastcancer detection.TABLE ... translational research in breast cancer. 2-year period. Program in imaging technology dedicated toresearch and development for early detectionand diagnosis of breast cancer. Breast Cancer Research Foundation;...
... postmenopausal breast cancer. Cancer 53:1020-4, 1984. 9. Pathak DR, Speizer FE, Willett WC, Rosner B, Lipnick RJ: Parity and breastcancer risk: possible effect on age at diagnosis. Int J Cancer 37:21-5, ... Relation between parity and risk of (a) early breastcancer and (b) late breast cancer. Table 2 . Summary of the results on the relationship between breastcancer and reproductive factors according ... influence breast cancer risk differently according to age at diagnosis of breast cancer. Through a Medline/Pubmed search, 26 articles providing risk estimates by age at diagnosis of breast cancer...
... for breast cancer genes, breastcancer preventive medications, and media attention to the breastcancer dangers associated with different lifestyles, envi-ronments, and medications have also ... opinion waspessimistic about curing breast or other cancers. Surgeons in the earlierperiod believed that mastectomies did not cure breastcancer but rather Breast Cancer and Time, 1900–1970 365controlled ... appear” (Marcosson 1944, 36). Looking forward in time, cancer Breast Cancer and Time, 1900–1970 383ReferencesAdair, F.E. 1943. The Doctor Looks at Women and Their Problem of Cancer of the Breast. ...
... diagnosed with breast cancer? 3. What is the clinical validity of these tests in women diagnosed with breast cancer? a. How well does this testing predict recurrence rates for breastcancer when ... women diagnosed with breast cancer? a. How well does this testing predict recurrence rates for breastcancer compared to standard prognostic approaches? Specifically, how much do these tests ... Article does not involve one of the three gene expression tests of interest: 659 No original data or original analyses: 75 Study does not involve women: 2 Does not involve breastcancer patients:...